Cantargia AB (FRA:7V3) Total Long-Term Assets : €0.48 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Cantargia AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Cantargia AB's Total Long-Term Assets for the quarter that ended in Mar. 2025 was €0.48 Mil.

Cantargia AB Total Long-Term Assets Historical Data

The historical data trend for Cantargia AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantargia AB Total Long-Term Assets Chart

Cantargia AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

Get a 7-Day Free Trial

1.24

0.93

1.18

0.85

0.53

Cantargia AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Assets	Get a 7-Day Free Trial															0.76	0.69	0.61	0.53	0.48

Cantargia AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Cantargia AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Cantargia AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantargia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (FRA:7V3) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

CANTA:Sweden

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.cantargia.com

Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB Headlines

No Headlines